Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

PET∕CT imaging evidence of FUS-mediated (18)F-FDG uptake changes in rat brain.

Kim H, Park MA, Wang S, Chiu A, Fischer K, Yoo SS.

Med Phys. 2013 Mar;40(3):033501. doi: 10.1118/1.4789916.

2.

Estimation of the spatial profile of neuromodulation and the temporal latency in motor responses induced by focused ultrasound brain stimulation.

Kim H, Lee SD, Chiu A, Yoo SS, Park S.

Neuroreport. 2014 May 7;25(7):475-9. doi: 10.1097/WNR.0000000000000118.

3.

Focused ultrasound-mediated non-invasive brain stimulation: examination of sonication parameters.

Kim H, Chiu A, Lee SD, Fischer K, Yoo SS.

Brain Stimul. 2014 Sep-Oct;7(5):748-56. doi: 10.1016/j.brs.2014.06.011. Epub 2014 Jul 2.

4.

Quantitative assessment of cerebral glucose metabolic rates after blood-brain barrier disruption induced by focused ultrasound using FDG-MicroPET.

Yang FY, Chang WY, Chen JC, Lee LC, Hung YS.

Neuroimage. 2014 Apr 15;90:93-8. doi: 10.1016/j.neuroimage.2013.12.033. Epub 2013 Dec 22.

PMID:
24368263
5.

Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.

Wu A, Zheng H, Kraenzle J, Biller A, Vanover CD, Proctor M, Sherwood L, Steffen M, Ng C, Mollura DJ, Jonsson CB.

ILAR J. 2012;53(1):E9-21. doi: 10.1093/ilar.53.1.9.

6.

Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth.

Flores LG 2nd, Yeh HH, Soghomonyan S, Young D, Bankson J, Hu Q, Alauddin M, Huff V, Gelovani JG.

Mol Imaging Biol. 2013 Apr;15(2):175-85. doi: 10.1007/s11307-012-0588-5.

7.

Towards a reproducible protocol for repetitive and semi-quantitative rat brain imaging with (18) F-FDG: exemplified in a memantine pharmacological challenge.

Deleye S, Verhaeghe J, wyffels L, Dedeurwaerdere S, Stroobants S, Staelens S.

Neuroimage. 2014 Aug 1;96:276-87. doi: 10.1016/j.neuroimage.2014.04.004. Epub 2014 Apr 13.

PMID:
24736171
8.

Efficiency of drug delivery enhanced by acoustic pressure during blood-brain barrier disruption induced by focused ultrasound.

Yang FY, Lee PY.

Int J Nanomedicine. 2012;7:2573-82. doi: 10.2147/IJN.S31675. Epub 2012 May 23.

9.

The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.

Park J, Zhang Y, Vykhodtseva N, Jolesz FA, McDannold NJ.

J Control Release. 2012 Aug 20;162(1):134-42. doi: 10.1016/j.jconrel.2012.06.012. Epub 2012 Jun 15.

10.

Focused ultrasound-mediated noninvasive blood-brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters.

Shin J, Kong C, Cho JS, Lee J, Koh CS, Yoon MS, Na YC, Chang WS, Chang JW.

Neurosurg Focus. 2018 Feb;44(2):E15. doi: 10.3171/2017.11.FOCUS17627.

PMID:
29385915
11.

Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.

Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.

Invest Radiol. 2013 May;48(5):247-55. doi: 10.1097/RLI.0b013e31828d56a1.

PMID:
23519008
12.

Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.

Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.

Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.

PMID:
22999369
13.

Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.

Heusch P, Buchbender C, Köhler J, Nensa F, Gauler T, Gomez B, Reis H, Stamatis G, Kühl H, Hartung V, Heusner TA.

J Nucl Med. 2014 Mar;55(3):373-8. doi: 10.2967/jnumed.113.129825. Epub 2014 Feb 6.

14.

Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.

Shimoji K, Ravasi L, Schmidt K, Soto-Montenegro ML, Esaki T, Seidel J, Jagoda E, Sokoloff L, Green MV, Eckelman WC.

J Nucl Med. 2004 Apr;45(4):665-72.

15.

Detection of intracerebral hemorrhage and transient blood-supply shortage in focused-ultrasound-induced blood-brain barrier disruption by ultrasound imaging.

Fan CH, Liu HL, Huang CY, Ma YJ, Yen TC, Yeh CK.

Ultrasound Med Biol. 2012 Aug;38(8):1372-82. doi: 10.1016/j.ultrasmedbio.2012.03.013. Epub 2012 May 12.

PMID:
22579546
16.

Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.

Yoshida K, Ogasawara K, Saura H, Saito H, Kobayashi M, Yoshida K, Terasaki K, Fujiwara S, Ogawa A.

J Neurosurg. 2015 Dec;123(6):1546-54. doi: 10.3171/2014.12.JNS142339. Epub 2015 Jul 31.

PMID:
26230467
17.
18.
19.

(18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.

Asabella AN, Cimmino A, Altini C, Notaristefano A, Rubini G.

Hell J Nucl Med. 2011 Sep-Dec;14(3):311-2.

PMID:
22087457
20.

PET/CT imaging reveals unrivaled placental avidity for glucose compared to other tissues.

Sawatzke AB, Norris AW, Spyropoulos F, Walsh SA, Acevedo MR, Hu S, Yao J, Wang C, Sunderland JJ, Boles Ponto LL.

Placenta. 2015 Feb;36(2):115-20. doi: 10.1016/j.placenta.2014.12.009. Epub 2014 Dec 23.

Supplemental Content

Support Center